Literature DB >> 12722810

MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation Facility.

E Bräuer-Krisch1, A Bravin, M Lerch, A Rosenfeld, J Stepanek, M Di Michiel, J A Laissue.   

Abstract

Preclinical experiments are carried out with approximately 20-30 microm wide, approximately 10 mm high parallel microbeams of hard, broad-"white"-spectrum x rays (approximately 50-600 keV) to investigate microbeam radiation therapy (MRT) of brain tumors in infants for whom other kinds of radiotherapy are inadequate and/or unsafe. Novel physical microdosimetry (implemented with MOSFET chips in the "edge-on" mode) and Monte Carlo computer-simulated dosimetry are described here for selected points in the peak and valley regions of a microbeam-irradiated tissue-equivalent phantom. Such microbeam irradiation causes minimal damage to normal tissues, possible because of rapid repair of their microscopic lesions. Radiation damage from an array of parallel microbeams tends to correlate with the range of peak-valley dose ratios (PVDR). This paper summarizes comparisons of our dosimetric MOSFET measurements with Monte Carlo calculations. Peak doses at depths <22 mm are 18% less than Monte Carlo values, whereas those depths >22 mm and valley doses at all depths investigated (2 mm-62 mm) are within 2-13% of the Monte Carlo values. These results lend credence to the use of MOSFET detector systems in edge-on mode for microplanar irradiation dosimetry.

Entities:  

Mesh:

Year:  2003        PMID: 12722810     DOI: 10.1118/1.1562169

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  12 in total

1.  The influence of the channel size on the reduction of side effects in microchannel proton therapy.

Authors:  Stefanie Girst; Christoph Greubel; Judith Reindl; Christian Siebenwirth; Olga Zlobinskaya; Günther Dollinger; Thomas E Schmid
Journal:  Radiat Environ Biophys       Date:  2015-05-09       Impact factor: 1.925

2.  Fiber-optic detector for real time dosimetry of a micro-planar x-ray beam.

Authors:  Matthew D Belley; Ian N Stanton; Mike Hadsell; Rachel Ger; Brian W Langloss; Jianping Lu; Otto Zhou; Sha X Chang; Michael J Therien; Terry T Yoshizumi
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

3.  Reduced side effects by proton microchannel radiotherapy: study in a human skin model.

Authors:  Olga Zlobinskaya; Stefanie Girst; Christoph Greubel; Volker Hable; Christian Siebenwirth; Dietrich W M Walsh; Gabriele Multhoff; Jan J Wilkens; Thomas E Schmid; Günther Dollinger
Journal:  Radiat Environ Biophys       Date:  2012-12-28       Impact factor: 1.925

4.  Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas.

Authors:  H M Smilowitz; H Blattmann; E Bräuer-Krisch; A Bravin; M Di Michiel; J-O Gebbers; A L Hanson; N Lyubimova; D N Slatkin; J Stepanek; J A Laissue
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

5.  Biodosimetric quantification of short-term synchrotron microbeam versus broad-beam radiation damage to mouse skin using a dermatopathological scoring system.

Authors:  R C U Priyadarshika; J C Crosbie; B Kumar; P A W Rogers
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

6.  Transient and Efficient Vascular Permeability Window for Adjuvant Drug Delivery Triggered by Microbeam Radiation.

Authors:  Sarah Sabatasso; Cristian Fernandez-Palomo; Ruslan Hlushchuk; Jennifer Fazzari; Stefan Tschanz; Paolo Pellicioli; Michael Krisch; Jean A Laissue; Valentin Djonov
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

7.  In vivo pink-beam imaging and fast alignment procedure for rat brain lesion microbeam radiation therapy.

Authors:  Raphaël Serduc; Gilles Berruyer; Thierry Brochard; Michel Renier; Christian Nemoz
Journal:  J Synchrotron Radiat       Date:  2010-03-20       Impact factor: 2.616

8.  Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy.

Authors:  Audrey Bouchet; Nathalie Sakakini; Michèle El Atifi; Céline Le Clec'h; Elke Brauer; Anaïck Moisan; Pierre Deman; Pascal Rihet; Géraldine Le Duc; Laurent Pelletier
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Beam size limit for pencil minibeam radiotherapy determined from side effects in an in-vivo mouse ear model.

Authors:  Matthias Sammer; Katharina Teiluf; Stefanie Girst; Christoph Greubel; Judith Reindl; Katarina Ilicic; Dietrich W M Walsh; Michaela Aichler; Axel Walch; Stephanie E Combs; Jan J Wilkens; Günther Dollinger; Thomas E Schmid
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

10.  An evaluation of dose equivalence between synchrotron microbeam radiation therapy and conventional broad beam radiation using clonogenic and cell impedance assays.

Authors:  Mohammad Johari Ibahim; Jeffrey C Crosbie; Yuqing Yang; Marina Zaitseva; Andrew W Stevenson; Peter A W Rogers; Premila Paiva
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.